Activation of the JAK-STAT Signaling Pathway after In Vitro Stimulation with IFNß in Multiple Sclerosis Patients According to the Therapeutic Response to IFNß
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Activation of the JAK-STAT Signaling Pathway after In Vitro Stimulation with IFNß in Multiple Sclerosis Patients According to the Therapeutic Response to IFNß
Authors
Keywords
Monocytes, JAK-STAT signaling cascade, Cytotoxic T cells, Multiple sclerosis, T cells, Magnetic resonance imaging, Interferons, Phosphorylation
Journal
PLoS One
Volume 12, Issue 1, Pages e0170031
Publisher
Public Library of Science (PLoS)
Online
2017-01-20
DOI
10.1371/journal.pone.0170031
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Type I/II cytokines, JAKs and new strategies for treating autoimmune diseases
- (2015) Daniella M. Schwartz et al. Nature Reviews Rheumatology
- Type I interferon responses in rhesus macaques prevent SIV infection and slow disease progression
- (2014) Netanya G. Sandler et al. NATURE
- Body fluid biomarkers in multiple sclerosis
- (2013) Manuel Comabella et al. LANCET NEUROLOGY
- Structural basis of a unique interferon-β signaling axis mediated via the receptor IFNAR1
- (2013) Nicole A de Weerd et al. NATURE IMMUNOLOGY
- STAT1 expression and activation is increased in lesional psoriatic skin
- (2012) A. Hald et al. BRITISH JOURNAL OF DERMATOLOGY
- JAK and STAT Signaling Molecules in Immunoregulation and Immune-Mediated Disease
- (2012) John J. O'Shea et al. IMMUNITY
- The JAK-STAT Pathway at Twenty
- (2012) George R. Stark et al. IMMUNITY
- Janus-like effects of type I interferon in autoimmune diseases
- (2012) Robert C. Axtell et al. IMMUNOLOGICAL REVIEWS
- The interferons and their receptors-distribution and regulation
- (2012) Nicole A de Weerd et al. IMMUNOLOGY AND CELL BIOLOGY
- Constitutive Phosphorylation of Interferon Receptor A-Associated Signaling Proteins in Systemic Lupus Erythematosus
- (2012) Gabriela Ramírez-Vélez et al. PLoS One
- Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
- (2011) Chris H. Polman et al. ANNALS OF NEUROLOGY
- The Mechanism of Action of Interferon-β in Relapsing Multiple Sclerosis
- (2011) Bernd C. Kieseier CNS DRUGS
- USP18-Based Negative Feedback Control Is Induced by Type I and Type III Interferons and Specifically Inactivates Interferon α Response
- (2011) Véronique François-Newton et al. PLoS One
- The role of cell type-specific responses in IFN- therapy of multiple sclerosis
- (2011) J. A. Zula et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A type I interferon signature in monocytes is associated with poor response to interferon-β in multiple sclerosis
- (2009) M. Comabella et al. BRAIN
- Neutralizing antibodies against IFN beta in patients with multiple sclerosis: A comparative study of two cytopathic effect tests (CPE) for their detection
- (2009) B. Oliver et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Measures in the first year of therapy predict the response to interferon β in MS
- (2009) J Río et al. Multiple Sclerosis Journal
- Ligand-independent pathway that controls stability of interferon alpha receptor
- (2008) Jianghuai Liu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More